{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:44:50Z","timestamp":1782996290314,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jneuroim.2009.02.009","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T07:45:18Z","timestamp":1237448718000},"page":"63-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Interleukin-10 promoter polymorphisms in myasthenia gravis"],"prefix":"10.1016","volume":"210","author":[{"given":"Espen Homleid","family":"Alseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Linda","family":"Nakkestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aarseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Olve","family":"Skeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6603","key":"10.1016\/j.jneuroim.2009.02.009_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"issue":"3 Pt 1","key":"10.1016\/j.jneuroim.2009.02.009_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.44.3_Part_1.551","article-title":"Familial autoimmune myasthenia gravis","volume":"44","author":"Bergoffen","year":"1994","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2009.02.009_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1572-0241.2006.00501.x","article-title":"TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of \u22121082 AA low producer IL-10 genotype with steroid dependency","volume":"101","author":"Castro-Santos","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2009.02.009_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1405.042","article-title":"CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"1132","author":"Conti-Fine","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.02.009_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y","article-title":"Polymorphic haplotypes of the interleukin-10 5\u2032 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis","volume":"42","author":"Crawley","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.02.009_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00179791","article-title":"An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes","volume":"35","author":"Degli-Esposti","year":"1992","journal-title":"Immunogenetics"},{"issue":"16","key":"10.1016\/j.jneuroim.2009.02.009_bib8","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1073\/pnas.95.16.9465","article-title":"Interleukin 10 secretion in relation to human IL-10 locus haplotypes","volume":"95","author":"Eskdale","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.gene.6363656","article-title":"Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus","volume":"1","author":"Eskdale","year":"1999","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s002510050250","article-title":"Mapping of the human IL10 gene and further characterization of the 5\u2032 flanking sequence","volume":"46","author":"Eskdale","year":"1997","journal-title":"Immunogenetics"},{"issue":"8","key":"10.1016\/j.jneuroim.2009.02.009_bib11","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-5728(97)00262-2","article-title":"Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse","volume":"85","author":"Gayo","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2009.02.009_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0896-8411(90)90148-L","article-title":"Immunoglobulin allotypes in myasthenia gravis patients with a thymoma","volume":"3","author":"Gilhus","year":"1990","journal-title":"J. Autoimmun."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2009.02.009_bib14","first-page":"82","article-title":"Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease","volume":"94","author":"Huang","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1468-1331.2000.00056.x","article-title":"Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis","volume":"7","author":"Huang","year":"2000","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2004-829585","article-title":"Pathophysiology of myasthenia gravis","volume":"24","author":"Hughes","year":"2004","journal-title":"Semin. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2009.02.009_bib17","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.154.9.4341","article-title":"The role of IL-10 in human B cell activation, proliferation, and differentiation","volume":"154","author":"Itoh","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.009_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60237-0","article-title":"Regulation of human B lymphocyte activation, proliferation, and differentiation","volume":"40","author":"Jelinek","year":"1987","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.1995.1001","article-title":"Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines","volume":"7","author":"Kube","year":"1995","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.jneuroim.2009.02.009_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.41.5.394","article-title":"Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications","volume":"41","author":"Lefvert","year":"1978","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2009.02.009_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009748809102973","article-title":"Regulation of human B lymphocyte responsiveness","volume":"76","author":"Lipsky","year":"1988","journal-title":"Scand. J. Rheumatol. Suppl."},{"issue":"4","key":"10.1016\/j.jneuroim.2009.02.009_bib22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.4049\/jimmunol.152.4.1821","article-title":"Expression cloning and characterization of a human IL-10 receptor","volume":"152","author":"Liu","year":"1994","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00171792","article-title":"Large transcripts and sequence from a polymorphic 170\u00a0kb MHC region implicated in susceptibility to autoimmune disease","volume":"39","author":"Marshall","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2009.02.009_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1254.032","article-title":"T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"998","author":"Milani","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2009.02.009_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2009.02.009_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2222.2004.01824.x","article-title":"Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes","volume":"34","author":"Mozo","year":"2004","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.36.1.78","article-title":"Myasthenia gravis in identical twins","volume":"36","author":"Murphy","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2009.02.009_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80533-6","article-title":"Cytokines induce the development of functionally heterogeneous T helper cell subsets","volume":"8","author":"O Garra","year":"1998","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2009.02.009_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(97)00174-4","article-title":"FcgammaRIIA and FcgammaRIIIB polymorphisms in myasthenia gravis","volume":"81","author":"Raknes","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.02.009_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol. Today"},{"issue":"11","key":"10.1016\/j.jneuroim.2009.02.009_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","article-title":"The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies","volume":"57","author":"Romi","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2009.02.009_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis","volume":"183","author":"Skeie","year":"2006","journal-title":"Acta. Neurol. Scand. Suppl."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08916939709003854","article-title":"Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes","volume":"26","author":"Skeie","year":"1997","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.jneuroim.2009.02.009_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archneur.56.4.457","article-title":"TNFA and TNFB polymorphisms in myasthenia gravis","volume":"56","author":"Skeie","year":"1999","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib35","first-page":"1","article-title":"Myasthenia gravis","volume":"43","author":"Somnier","year":"1996","journal-title":"Dan. Med. Bull."},{"issue":"22","key":"10.1016\/j.jneuroim.2009.02.009_bib36","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1073\/pnas.83.22.8699","article-title":"Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex","volume":"83","author":"Spies","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.jneuroim.2009.02.009_bib37","doi-asserted-by":"crossref","first-page":"21053","DOI":"10.1016\/S0021-9258(19)36892-9","article-title":"Characterization of interleukin-10 receptors on human and mouse cells","volume":"268","author":"Tan","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur. J. Immunogenet."},{"issue":"43","key":"10.1016\/j.jneuroim.2009.02.009_bib39","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.02.009_bib40","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"Vincent","year":"2002","journal-title":"Adv. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1084\/jem.178.1.175","article-title":"Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans","volume":"178","author":"Wogensen","year":"1993","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jneuroim.2009.02.009_bib42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.179.4.1379","article-title":"Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice","volume":"179","author":"Wogensen","year":"1994","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2009.02.009_bib43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2009.02.009_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1054\/jocn.2001.1028","article-title":"Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis","volume":"9","author":"Yoshikawa","year":"2002","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2009.02.009_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(00)00411-2","article-title":"Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR","volume":"113","author":"Zhang","year":"2001","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:15Z","timestamp":1759047075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0165572809000666"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-10 promoter polymorphisms in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}